Current perspective on emergence, diagnosis and drug resistance in Candida auris
- PMID: 28652784
- PMCID: PMC5476417
- DOI: 10.2147/IDR.S116229
Current perspective on emergence, diagnosis and drug resistance in Candida auris
Abstract
Candida auris is an emerging fungus that presents a serious threat to global health. The organism is difficult to identify using conventional biochemical methods. C. auris has also attracted attention because of its reduced susceptibility to azoles, polyenes, and echinocandins, with a few strains even resistant to all three classes of antifungals. In this review paper we discuss the trends in emergence of C. auris in different parts of the world, associated risk factors, drug resistance, and diagnostic challenges. Strategies for prevention and therapeutic options for such infections is also addressed.
Keywords: Candida haemulonii; Candidemia; drug resistance; outbreak.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures
References
-
- Shao LC, Sheng CQ, Zhang WN. Recent advances in the study of antifungal lead compounds with new chemical scaffolds. Yao Xue Xue Bao. 2007;42:1129–1136. Chinese. - PubMed
-
- Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis. 2003;3:685–702. - PubMed
-
- Silva S, Henriques M, Martins A, Oliveira R, Williams D, Azeredo J. Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition. Med Mycol. 2009;47(7):681–689. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
